Interaction of phencyclidine and its new adamantyl derivatives with muscarinic receptors

Ayala Gabrielevitz*, Yoel Kloog, Asher Kalir, David Balderman, Mordechai Sokolovsky

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

The antimuscarinic potency of new derivatives of phencyclidine containing the adamantyl moiety was evaluated in the guinea pig ileum test. The drugs tested competitively inhibited the acetylcholine-induced contractions. Kd values were calculated and compared to those obtained by direct binding to the muscarinic receptors from mouse brain. The new derivative, |1-(2-phenyl-2-adamantyl) piperidine| was found to be the most potent muscarinic antagonist among the many phencyclidine derivatives known to date. The results are discussed in terms of the acetylcholine-like molecular arrangement of these derivatives that gives rise to a characteristic muscarinic interaction.

Original languageEnglish
Pages (from-to)89-95
Number of pages7
JournalLife Sciences
Volume26
Issue number2
DOIs
StatePublished - 14 Jan 1980

Fingerprint

Dive into the research topics of 'Interaction of phencyclidine and its new adamantyl derivatives with muscarinic receptors'. Together they form a unique fingerprint.

Cite this